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The intracellular trafficking of the epidermal growth factor receptor (EGFR) is regulated by a cross-talk between
calmodulin (CaM) and protein kinase C (PKC). On inhibition of CaM, PKC promotes the formation of enlarged early
endosomes and blocks EGFR recycling and degradation. Here, we show that PKC impairs EGFR trafficking due to the
formation of an F-actin coat surrounding early endosomes. The PKC-induced polymerization of actin is orchestrated by
the Arp2/3 complex and requires the interaction of cortactin with PKC. Accordingly, inhibition of actin polymerization
by using cytochalasin D or by overexpression of active cofilin, restored the normal morphology of the organelle and the
recycling of EGFR. Similar results were obtained after down-regulation of cortactin and the sequestration of the Arp2/3
complex. Furthermore we demonstrate an interaction of cortactin with CaM and PKC, the latter being dependent on CaM
inhibition. In summary, this study provides the first evidence that CaM and PKC organize actin dynamics in the early
endosomal compartment, thereby regulating the intracellular trafficking of EGFR.
INTRODUCTION
Calmodulin (CaM) is a ubiquitous small calcium sensor that
regulates a variety of cellular processes in a spatial and
temporal manner within the cell (Toutenhoofd and Strehler,
2000). Microenvironment variations in the concentration of
CaM may be critical to the control of cellular processes that
involve specific and high-affinity CaM-binding proteins
(Berridge et al., 2000; Carafoli, 2002; Kahl and Means, 2003).
We have previously shown that CaM is crucial to the
regulation of the dynamics of endosomes. In particular, in
the presence of W13, a highly specific CaM antagonist, traf-
ficking is blocked in early endosomes, thereby interfering
with transport toward degradation and recycling pathways.
This blockage was associated with a dramatic alteration of
the morphology and size of early endosomes (Tebar et al.,
2002; Lladó et al., 2004). Furthermore we showed that a
cross-talk between CaM and protein kinase C (PKC) is
involved in the regulation of the budding from the early
endocytic compartment (Lladó et al., 2004).
Several lines of evidence implicate the actin cytoskeleton
in the CaM- and PKC-mediated regulation of vesicular
trafficking. Because actin contributes to the maintenance of
organelle stability (Apodaca, 2001), swelling and morpho-
logical changes observed in response to CaM/PKC activity
(Lladó et al., 2004) may involve altered actin dynamics.
Moreover, several CaM-binding proteins and PKC sub-
strates are also actin-binding proteins, including -actinin,
adducin, and myristoylated alanine-rich protein kinase C
substrate (MARCKS) (Chakravarthy et al., 1999). Finally,
RhoGTPases and CaM-binding proteins responsible for fu-
sion-fission events during vesicular trafficking also depend
on actin filaments for pinch-off and vesicular movement
(Mayorga et al., 1994; Mu et al., 1995; Colombo et al., 1997;
Ridley, 2001; Burgoyne and Clague, 2003; Lawe et al., 2003;
Donaldson, 2005).
The actin cytoskeleton has been shown to play a vital role
in controlling the multifaceted process of endocytosis, in-
cluding endocytosis at different ports of entry such as clath-
rin/caveolae-dependent mechanisms and the fusion of ves-
icles with early endosomes (Apodaca, 2001; Lanzetti et al.,
2001; Taunton, 2001; Stamnes, 2002; Ayscough, 2004; Kak-
sonen et al., 2006). Molecules such as dynamin, syndapin,
Huntingtin-interacting protein 1 related (HIP1R), Abp1, syn-
aptojanin, neural Wiskott-Aldrich syndrome protein (N-
WASP), intersectin, and cortactin link the endocytic machin-
ery to the actin cytoskeleton (Qualmann et al., 2000; Jeng and
Welch, 2001; Schafer, 2002; da Costa et al., 2003).
More precisely, cortactin activates Arp2/3 complex and
regulates the formation of branched actin networks during
various cellular processes (Daly, 2004). In trafficking events,
cortactin has been involved in clathrin-mediated endocyto-
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sis as well as in pinocytosis, regulation of epidermal growth
factor receptor (EGFR) degradation, or endosomal position-
ing (McNiven et al., 2000; Cao et al., 2003, 2005; Lynch et al.,
2003; Cabezas et al., 2005; Merrifield et al., 2005; Sauvonnet et
al., 2005; Timpson et al., 2005; Zhu et al., 2005; Mettlen et al.,
2006; Le Clainche et al., 2007).
Here, we analyze the mechanisms by which CaM regu-
lates membrane trafficking along the endocytic pathway. We
show that when CaM is inhibited, PKC activation leads to
F-actin accumulation around the early endosomes, blocking
receptor trafficking. Furthermore, we demonstrate that
Arp2/3 complex and cortactin, together with PKC, supply
the molecular machinery required for the formation of the
actin coat associated with enlarged early endosomes. Fi-
nally, this study shows a new role for actin, through cortac-
tin and Arp2/3 complex, in the control of membrane traf-
ficking events at the early endocytic compartment.
MATERIALS AND METHODS
Reagents
Mouse receptor-grade epidermal growth factor (EGF) and W13 were from
Sigma Chemical (Madrid, Spain). Rottlerin, Y27632, and cytochalasin D were
from Calbiochem (Merck Eurolab KGaA, Darmstadt, Germany). Transferrin
conjugated with tetramethylrhodamine B isothiocyanate (TRITC) was from
Invitrogen (Carlsbad, CA). Primary antibodies used were as follows: mouse
monoclonal anti-EGFR (American Type Culture Collection, Manassas, VA),
mouse monoclonal anti-actin (Valeant Pharmaceuticals, Costa Mesa, CA),
rabbit anti-RhoB (Bethyl Laboratories, Montgomery, TX), mouse monoclonal
anti-early endosomal antibody (EEA)1 (BD Biosciences Transduction Labora-
tories, Erembodegem, Belgium), mouse monoclonal anti-p16-Arc (Synaptic
Systems, Go¨ttingen, Germany), rabbit anti-WASP family Verprolin-homolo-
gous protein (WAVE) and mouse monoclonal anti-cortactin (Upstate Biotech-
nology, Charlottesville, VA), rabbit anti-green fluorescent protein (GFP) (Ab-
cam, Cambridge, United Kingdom), rabbit anti-PKC (Santa Cruz
Biotechnology, Santa Cruz, CA). Peroxidase-labeled antibodies and SDS-
polyacrylamide gel electrophoresis (PAGE) molecular weight markers were
from Bio-Rad (Hercules, CA). 125I-EGF and calmodulin-Sepharose beads were
purchased from GE Healthcare (Chalfont St. Giles, England). Protein A bound
to Sepharose was from Pierce Chemical (Rockford, IL). Yellow fluorescent
protein (YFP)-actin and GFP-tagged plasmids were from Clontech (Palo Alto,
CA). GFP-WA and GFP-WASPWA, myc RhoB wt, pSUPER RhoB, GFP-
PKC (Ling et al., 2004), and flag cortactin (Weed et al., 2000) were kindly
provided by M. Way (London Research Institute, London, United Kingdom),
A. J. Ridley (Ludwig Institute for Cancer Research and Department of Bio-
chemistry and Molecular Biology, University College London, London,
United Kingdom), C. Larsson (Lund University, Lund, Sweden), and S. A.
Weed (West Virginia University, Morgantown, WV), respectively.
Cell Culture
Normal rat kidney cells (NRK) were grown in DMEM containing 5% fetal calf
serum (FCS), pyruvic acid, antibiotics, and glutamine. DMEM and FCS were
purchased from Biological Industries (Beit Haemek, Israel). In some experi-
ments, we also used Green monkey kidney cells (COS1), Vero cells, or HeLa
cells.
Immunofluorescence Staining
Cells grown on coverslips were fixed with freshly prepared 4% para-formal-
dehyde for 12 min at room temperature and mildly permeabilized with
phosphate-buffered saline (PBS) containing 0.1% Triton X-100, 0.1% bovine
serum albumin (BSA) at room temperature for 3 min. Coverslips were then
incubated in the same buffer, in which Triton X-100 was omitted, at room
temperature for 1 h with the primary antibody, washed intensively, and then
incubated with adequate secondary antibodies labeled with Alexa Fluor 488,
Alexa Fluor 594 (Invitrogen), or cyanine (Cy)5 (Jackson ImmunoResearch
Laboratories, Soham Cambridgeshire, United Kingdom). Both primary and
secondary antibody solutions were precleared by centrifugation at 14,000  g
for 10 min. In some experiments, phalloidin-conjugated to TRITC (Sigma
Chemical) or to Alexa Fluor 350 (Invitrogen) was incubated together with the
secondary antibodies. After staining, the coverslips were mounted in Mowiol
(Calbiochem). The images were recorded using an inverted epifluorescence
Axiovert 200M microscope (Carl Zeiss, Go¨ttingen, Germany) equipped with a
photometric coolSNAP HQ camera, all controlled by SlideBook 3.0.10.5 soft-
ware (Intelligent Imaging Innovation, Denver, CO) or a Leica TCS SL laser
scanning confocal spectral microscope (Leica Microsystems, Heidelberg or
Mannheim, Germany). Final analysis of deconvolved images was performed
using Adobe Photoshop 5.5 (Adobe Systems. Mountain View, CA) and Im-
ageJ (http://rsb.info.nih.gov/ij/).
Colocalization between p16 or cortactin and transferrin-TRITC on endo-
somes was quantified using the ImageJ program (Wayne Rasband, National
Institutes of Health) and the “Highlighting Colocalization” plugin (Pierre
Bourdoncle, Institute Jacques Monod, Service Imagerie, Paris, France). The
Highlighting Colocalization plug-in generated an image of colocalized points
(binary). A threshold image of transferrin-TRITC was created and colocaliza-
tion was expressed as the ratio between the area of colocalized points and the
threshold area of the corresponding image. At least 15 cells were analyzed for
each condition.
Generation and Expression of DNA Constructs
The original Flag-tagged human wild-type (wt)-cofilin in the pKEX-2-XR
plasmid (a kind gift of Y. Samstag, Ruprecht Karl University, Institute of
Immunology, Heidelberg, Germany) has been described previously (Nebl et
al., 1996). To obtain a recombinant cofilin S3A mutant fused to YFP, the point
mutation was introduced by polymerase chain reaction (PCR) by using a
primer containing serine 3 (TCC) mutated to alanine (GCC). Then, a Bgl
II/Hind III fragment was excised from the pKEX-2-XR plasmid and ligated
into an equally digested pEYFPC3 vector.
Transient expression of all plasmids was performed using Effectene
(QIAGEN, Valencia, CA). Cells were used for experiments 24 – 48 h after
transfection.
Suppression of Cortactin Expression by RNA Interference
(RNAi)
Knockdown of cortactin was performed as described previously (Timpson et
al., 2005). Briefly, 19-nucleotide RNAs were chemically synthesized (Ambion,
Austin, TX) based on the sequence 5-AAGCUGAGGGAGAAUGUCU-
UGU-3 (small interfering RNA; [siRNA]1) (Helwani et al., 2004) or 5-
GACUGGUUUUGGAGGCAAAUUUU-3 (siRNA2) (Engqvist-Goldstein et
al., 2004). siRNA against GFP was used as a control. For transfection Oligo-
fectamine (Invitrogen) was used following manufacturer’s instructions.
Recycling and Degradation of 125I-EGF
125I-EGF recycling and degradation were measured as described previously
(Kornilova et al., 1996). Briefly, cells in six-wells plates were incubated with 5
ng/ml 125I-EGF for 7 min at 37°C and washed in cold DMEM. The 125I-EGF
that had not been internalized during 37°C incubation was removed from the
cell surface by a 2.5-min acid wash (0.2 M sodium acetate, 0.5 M NaCl, pH
4.5). At this point cells are referred to as “125I-EGF-loaded cells.” Trafficking
of 125I-EGF-receptor complexes in these loaded cells was then initiated by
incubating the cells in fresh binding medium containing 100 ng/ml unlabeled
EGF and dimethyl sulfoxide, W13 (7.5 g/ml), or cytochalasin D (0.1 M) at
37°C for 30 min. Excess of unlabeled EGF in the medium and at the surface
prevented rebinding and reinternalization of recycled 125I-EGF. At the end of
the chase incubation, the medium was collected to measure the amount of
intact and degraded 125I-EGF by precipitation with trichloracetic acid (TCA).
Then, cells were incubated for 5 min with 0.2 M acetic acid, pH 2.8, containing
0.5 M NaCl at 4°C to determine the amount of surface-bound 125I-EGF.
Finally, cells were solubilized in 1 N NaOH to measure the amount of
intracellular 125I-EGF. The amount of recycled 125I-EGF was calculated by
adding the radioactivity counted on the cell surface and the TCA-precipitated
radioactivity in the medium during chase incubation, and the recycling or
degradation rate was expressed to the total of EGF molecules.
SDS-PAGE and Western Blotting
SDS-PAGE was carried out as described by Laemmli (1970). The protein
content of the samples was measured by the method of Bradford (Bradford,
1976; Bio-Rad). For Western blotting, 10–50 g of protein per well was
transferred electrophoretically at 60 V for 2 h at 4°C to Immobilon-P transfer
membranes (Millipore, Billerica, MA), and antigens were identified using
different antibodies diluted in Tris-buffered saline with 0.05% Tween 20.
Finally, the reaction product was detected using the ECL system (GE Health-
care).
Immunoprecipitation
HeLa cells grown on 100-mm dishes were transfected with flag pcDNA3
cortactin and phosphorylated (p)EGFP or pEGFP-PKC and split after 6 h on
60-mm dishes. Twenty hours later, cells were starved for 1 h and treated 
W13 in binding medium (DMEM, 0.1% BSA, 20 mM HEPES, pH 7.3). Cells
were then washed in PBS and solubilized by scraping with a rubber police-
man in TGH buffer (1% Triton X-100, 10% glycerol, 50 mM NaCl, 50 mM
HEPES, pH 7.3, 0.5% sodium deoxycholate, 1 mM sodium orthovanadate, 10
mM sodium fluoride, 1 mM phenylmethylsulfonyl fluoride, 10 mg/ml leu-
peptin, 10 mg/ml aprotinin) followed by gentle rotation for 10 min at 4°C.
Lysates were then centrifuged at 14,000  g for 10 min at 4°C. Supernatants
of transfected or not transfected cells were incubated with rabbit polyclonal
anti-GFP or monoclonal anti-cortactin antibodies for 2 h at 4°C and then for
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60 min after the addition of protein A or protein G-Sepharose, respectively.
Immunoprecipitates were washed twice in TGH buffer supplemented with
150 mM NaCl and then once without NaCl. SDS-polyacrylamide gels (12%)
were used to separate proteins. Proteins were then transferred to Immo-
bilon-P and immunoblotted using anti-cortactin, anti-PKC, or anti-GFP fol-
lowed by the appropriate peroxidase-conjugated secondary antibody and
ECL detection.
Affinity Chromatography with CaM-Sepharose
For pull-down assays with cellular lysates, HeLa cells in a 100-mm dish were
serum starved for 1 h, washed twice in ice-cold phosphate-buffered saline,
lysed with 0.5 ml of TGH buffer, gently rotated for 10 min at 4°C, and clarified
by centrifugation. Lysates (equalized for protein content) were incubated with
30 l of CaM-Sepharose for 2 h at 4°C in the presence of 1 mM CaCl2 or 5 mM
EGTA. The unbound fraction was collected by centrifugation, and the remain-
ing bound fraction was washed twice in TGH buffer containing CaCl2 or
EGTA supplemented with 100 mM NaCl and then once without NaCl. An
aliquot (25 l) of the unbound fraction and the total of the bound fraction
were analyzed by electrophoresis and Western blotting. A lysate from HeLa
cells was always loaded in the same gel as a control for the mobility of each
protein.
RESULTS
We have previously reported the effect of the CaM antago-
nist W13 on the morphology and dynamics of the endocytic
pathway. W13 treatment produced large aberrant endo-
somes containing early endocytic markers and internalized
EGF, dextran, and transferrin (Apodaca et al., 1994; Tebar et
al., 2002). The blockage in the ongoing trafficking from these
early endosomes was PKC dependent (Lladó et al., 2004).
CaM and PKC Regulates the Formation of an F-Actin
Coat Surrounding the Early Endosomes
To explore a possible connection between the actin cytoskel-
eton and morphologically aberrant early endosomes, we
first examined, in NRK cells,1 whether the endosomes pro-
duced by W13 contained actin. By means of immunofluo-
rescence, F-actin was labeled with phalloidin-TRITC, and
early endosomes were labeled with anti-EEA1. Untreated
(Figure 1A) and W12-treated (data not shown) NRK cells
showed an abundance of stress fibers and early endosomes
in the perinuclear region of the cell. In NRK cells treated
with W13, F-actin was found strongly associated with en-
larged early endosomes; this observation was concomitant
with a significant decrease (28%) in the number of stress
fibers in the cytoplasm. The staining with phalloidin also
showed F-actin along the plasma membrane (in both W13
and control cells) (Figure 1).
Higher magnification showed that individual early endo-
somes contained both EEA1 and F-actin. However, there
was a discontinuous, patched distribution of these two mol-
ecules at the membrane, showing different domains with
some areas of colocalization (see insets in Figure 1B).
To examine whether these early endosomes incorpo-
rated ectopically expressed actin, NRK cells (n  200)
were microinjected with YFP-actin expression vector and
then incubated for 60 min with W13 and for 30 min with
transferrin-TRITC at 37°C. Figure 1C shows that fluores-
cent actin clearly labels those early endosomes filled with
transferrin.
Next, to determine whether this F-actin coat was re-
sponsible for the arrest of ongoing trafficking, actin fila-
ments were disrupted using two types of depolymerizing
agents: cytochalasin D and the expression of constitu-
tively active YFP-cofilin (S3A) (Moriyama et al., 1996).
Cytochalasin D induced the disassembly of actin filaments
and a concurrent loss of the aberrant and W13-induced
early endosomes morphology (Figure 2A). Similar results
were obtained in COS1 cells expressing YFP-cofilin S3A
(Figure 2B). Both results indicated that, in cells depleted
of functional CaM, the formation of the F-actin coat is
responsible for the alteration of the morphology of early
endosomes and therefore might control the exit (budding)
from this compartment.
To further characterize the involvement of actin poly-
merization on the trafficking events from these early en-
dosomes, recycling and degradation of EGFR was quan-
tified using 125I-EGF, as described in Materials and
1 To better visualize the actin cytoskeleton or due to the different
efficiency of transfection or siRNA knockdown, we used the follow-
ing cell lines: NRK, COS1, Vero, and HeLa. W13 or rottlerin have the
same effect in all of the above-mentioned cell lines.
Figure 1. CaM regulates F-actin dynamics in early endosomes. (A)
NRK cells were incubated for 60 min with the specific CaM inhibitor
W13 (5 g/ml) at 37°C. Labeling with phalloidin-TRITC and anti-
EEA1 (Alexa Fluor 488) is shown. (B) High magnification of actin
patches surrounding endosomes of cells treated with W13 as de-
scribed in A. (C) NRK cells were microinjected with YFP-actin, DNA
expression vector, and incubated 60 min with W13 (5 g/ml) and 30
min with transferrin-TRITC at 37°C. Bars, 10 m.
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Methods. Supplemental Table S1, A and B, show the effects
of cytochalasin D on the recycling and degradation of the
EGF-receptor in control and W13-treated HeLa cells, re-
spectively. In control cells, F-actin disruption by cytocha-
lasin D inhibits recycling (20%) and degradation (30%)
of the receptor (Supplemental Table S1; similar results
were obtained with YFP-cofilinS3A expression, data not
shown). In addition, cytochalasin D or YFP-cofilinS3A
expression (data not shown) significantly restored EGF
receptor recycling, but not its degradation, when CaM is
inhibited (Supplemental Table S1). These results indicated
that actin polymerization participates in the regulation of
recycling as well as degradation of EGFR.
We have previously shown that when CaM was inhib-
ited, active PKC was necessary to inhibit EGFR recycling
from the early endocytic compartment (Lladó et al., 2004).
Thus, to determine whether PKC was also involved in
the formation of the F-actin coat when cells were depleted
of CaM, NRK cells were incubated with the PKC inhib-
itor rottlerin. The endocytic compartment was loaded
with transferrin-TRITC, and finally cells were double la-
beled with phalloidin. When both PKC and CaM were
inhibited, NRK cells showed a significant recovery in the
number of stress fibers, their early endosomes were
smaller and surrounded by less F-actin (Figure 3, compare
W13  rottlerin [bottom panels] with W13 panels).
Figure 2. Actin may control early endosome exit in cells treated with the CaM antagonist. (A) NRK cells were incubated for 45 min with
W13 (5 g/ml) and 30 min with the actin-depolymerizing agent cytochalasin D (1 M). Anti-EEA1 (Alexa Fluor 488) and phalloidin-TRITC
stainings are shown. Bar, 10 m. (B) Vero cells transiently expressing constitutively active YFP-cofilin (S3A) were treated with W13 for 60
min at 37°C. After fixation, the cells were immunolabeled with anti-EEA1 (Alexa Fluor 594) and phalloidin-TRITC. Bar, 10 m.
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PKC Regulates Endocytic Trafficking in
RhoB-overexpressing Cells
GTPases of the Rho family (e.g., Cdc42, Rac1, RhoA, RhoD,
and TC10) are important regulators of various membrane
trafficking events, but also of actin dynamics (Symons and
Rusk, 2003). In particular, RhoB is localized, at least in part,
to early endosomes (Adamson et al., 1992; Robertson et al.,
1995; Rondanino et al., 2007), and it has been shown that
overexpression of its constitutively active mutant slows the
transit of receptor-bound EGF between endocytic compart-
ments (Gampel et al., 1999; Fernandez-Borja et al., 2005;
Rondanino et al., 2007).
Because of these striking similarities between the effects of
RhoB overexpression and CaM inhibition, we investigated
whether RhoB could have a role in CaM-regulated endocytic
trafficking. Thus, COS1 cells were transfected with myc-
RhoBwt and then incubated with EGF, fixed, and triple
labeled with anti-myc, phalloidin-TRITC, and anti-EGFR. In
support of a link between RhoB and CaM and similar to the
results described above (Figures 1 and 2), overexpression of
RhoBwt produced large vesicular structures that were sur-
rounded by F-actin (Figure 4A).
To determine the effect of CaM inhibition on endosome
morphology upon RhoB knockdown (RhoB depletion is
shown in Figure 4B by Western blotting), cells were trans-
fected with pSUPER RhoB (a plasmid encoding for siRNA
targeting RhoB). In cells with reduced expression of RhoB,
endosomes were similar to those in nontransfected cells
Figure 3. A CaM and PKC interplay modulates actin on endosomes. NRK cells were preincubated with W13 (5 g/ml) for 30 min, treated
with the PKC-specific inhibitor rottlerin (5 M) for 30 min, and then 15 min with transferrin-TRITC (50 g/ml) at 37°C. EEA1 (Alexa Fluor
488), transferrin-TRITC, and phalloidin (Alexa Fluor 350) stainings are shown. Bar, 10 m.
Cortactin/Arp2/3 Regulate EGFR Recycling
Vol. 19, January 2008 21
Figure 4.
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(Figure 4B, top). However, in these RhoB-depleted cells, the
inhibition of CaM still produced large aberrant early endo-
somes (Figure 4B, bottom), indicating that RhoB is not in-
volved in the W13-inducible early endosome morphology.
Moreover, to confirm the data obtained upon siRNA-medi-
ated silencing of RhoB, we next investigated whether ROCK,
one of the most important RhoB effectors (Ridley, 2006), was
involved. To this end, NRK cells were treated with Y27632, a
specific Rho kinase (ROCK) inhibitor, and the early endosome
morphology and actin cytoskeleton were analyzed (Figure 4C).
ROCK inhibition clearly reduced the number of stress fibers
but early endosomes still showed normal size and location. As
shown in Figure 4C, the presence of Y27632 did not interfere
with the effect of W13 on early endosomes, and very large
EEA1-positive endosomes surrounded by F-actin were still
observed. Therefore, we conclude that RhoB was not necessary
for the altered morphology observed in early endosomes in the
absence of active CaM.
Finally, to address whether RhoB acts together with
PKC, COS1 cells were transfected with RhoB (as in Figure
4A) but now adding rottlerin, for 30 min. Triple labeling in
Figure 4D showed that the inhibition of PKC restored the
size of early endosomes enlarged by the overexpression of
RhoB. Quantification (in 900 cells) showed that treatment
with rottlerin reduced the number of RhoB-transfected cells
that contained more than five aberrant early endosomes
(with a diameter 350 nm) from 71 to 42%. Therefore, RhoB
overexpression and CaM inhibition converge in PKC to
regulate exit from early endosomes.
Arp2/3 Complex Participates in the Formation of the
Actin Coat in Early Endosomes
The key steps regulating actin dynamics, nucleation, and
elongation are catalyzed by a discrete number of proteins
(and/or protein complexes) (Revenu et al., 2004). Among
these, we have identified, by means of immunocytochemis-
try, several actin-binding proteins present in these large
early endosomes: annexins A1 and A2, -actinin, and
MARCKS (Supplemental Figure S1).
One possible explanation for the accumulation of F-actin
around early endosomes, in the absence of CaM, is an induced
local polymerization of actin. For this process, the actin related
protein (Arp)2/3 complex activity is crucial (Goley and Welch,
2006). The complex is inactive by itself, and it can be activated
through interaction with members of the N-WASP/WAVE
family, which are regulated by small GTPases such as Cdc42
and Rac1 (Stradal et al., 2004; Stradal and Scita, 2006). To
address the possible involvement of Arp2/3 complex in the
accumulation of F-actin in endosomes, we first examined
whether Arp2/3 complex was present in the large W13-in-
duced early endosomes. NRK cells were preincubated with
W13 and then treated with rottlerin. In cells treated with W13,
the anti-p16 (a subunit of Arp2/3 complex) (Welch et al., 1997)
specifically localized in large vesicular structures, some of them
containing internalized transferrin-TRITC (24.4%) (Figure 5A).
However, in the presence of rottlerin (W13) the staining of
endosomes was similar to that in control cells (14%).
Figure 4 (facing page). Comparison of RhoB and CaM roles in
endosomes. (A) Twenty-four hours after transfection with myc-RhoB
wt, COS1 cells were incubated with EGF (100 ng/ml; 15 min) at 37°C,
fixed, and triple-stained with anti-myc (Alexa Fluor 488), phalloidin-
TRITC and anti-EGFR (Cy5). (B) COS1 cells were transfected with
pSUPER RhoB, and, after 72 h of knockdown, cells were incubated
with W13 (5 g/ml; 60 min) at 37°C. EEA1 was detected with specific
antibody followed by Alexa Fluor 594. The extent of RhoB depletion is
shown by Western blotting. (C) NRK cells were preincubated with
W13 (5 g/ml; 30 min), treated with the ROCK inhibitor Y27632 (20
M) for the next 45 min and with transferrin-TRITC (50 g/ml) for the
last 15 min at 37°C. After fixation, cells were labeled with phalloidin-
Alexa Fluor 350 and anti-EEA1 (Alexa Fluor 488). Bar, 10m. (D) COS1
cells were transfected and treated as described in A, adding 5 M
rottlerin for 30 min. Bar, 10 m. On the right, quantification of the
number of RhoB-overexpressing cells presenting 5 or more enlarged
endosomes (diameter 350 nm) from two independent experiments
(performed as described above; n 900 cells) is represented. Each data
point represents value averaged (SD). ***p	 0.001 for Student’s t test,
indicating statistical significance of differences between EGF- and EGF-
 rottlerin-treated cells.
Figure 5. Arp2/3 participates in the CaM and PKC regulated
actin dynamics. (A) NRK cells were preincubated with W13 (5
g/ml; 30 min) and treated with rottlerin (5 M) and transferrin (50
g/ml) for 30 min at 37°C. p16, a subunit of the Arp2/3 complex
(Alexa Fluor 488) and transferrin-TRITC labeling are shown. (B)
Twenty-four hours after transfection with the WA domain of
N-WASP tagged with GFP (which binds and sequesters Arp2/3),
COS1 cells were incubated with W13 (5 g/ml; 90 min) and EGF
(100 ng/ml; 15 min) at 37°C. Next, cells were fixed and stained with
anti-EGFR (Alexa Fluor 594). Bar, 10 m.
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To examine the role of Arp2/3 complex in the morpho-
logical effect of W13 on endosomes, we transfected COS1
cells with the GFP-tagged WA domain of N-WASP, which
acts in a dominant-negative manner as it binds and seques-
ters Arp2/3 complex (Higgs et al., 1999; Moreau et al., 2000;
Marchand et al., 2001; Shao et al., 2006). COS1 cells were
incubated with W13 and EGF, fixed, and labeled with anti-
EGFR. In cells expressing the WA domain of N-WASP, W13
did not affect the enlargement of early endosomes (Figure
5B).
We have previously shown that W13 inhibits the recycling
of EGFR (and transferrin) (Tebar et al., 2002; Lladó et al.,
2004). Thus, to assess whether the blockage of Arp2/3 com-
plex upon WA overexpression restored the trafficking to-
ward the recycling pathway, cells were transfected with the
WA construct, incubated with 125I-EGF for 7 min, and then
treated with W13. In cells transfected with the WA construct
(efficiency of transfection60%), the recycling of EGF-EGFR
was partially but significantly recovered (25%) (Supplemen-
tal Table S2A). In addition, overexpression of the WA do-
main in controls significantly inhibited the recycling of EGF-
EGFR (Supplemental Table S2A). This seems like a moderate
effect (11%), but considering the incomplete transfection ef-
ficiency, the statistical significance of these findings suggests
a physiological role of Arp2/3 complex in receptor recy-
cling.
Different pathways involving the actin nucleation promot-
ing factors (NPFs) converge for the activation of Arp2/3-
mediated actin polymerization, including N-WASP, WAVE,
and cortactin (Goley and Welch, 2006). To determine which
of these three is operative when CaM is inhibited, we first
used a dominant negative of N-WASP (N-WASPWA-GFP)
(Moreau et al., 2000). The expression of this N-WASP mu-
tant, which does not bind to Arp2/3 complex, did not inter-
fere with the effect of W13 on the formation of aberrant early
endosomes (Figure 6A) or in the blockage of the recycling of
125I-EGF (Supplemental Table S2B).
In addition, when NRK cells were labeled with anti-
WAVE together with transferrin-TRITC, WAVE was pre-
dominantly localized at the plasma membrane even after the
treatment with W13. Large endocytic and transferrin-
TRITC–positive structures produced by the W13 treatment
were not labeled with anti-WAVE (Figure 6B). Therefore,
neither of these two NPFs seemed to participate in the
activation of Arp2/3 complex.
Cortactin Is Involved in the Regulation of EGF Recycling
from Early Endosomes
Cortactin is a multidomain protein consisting of an NH2-
terminal acidic region that binds to the Arp2/3 complex, a
fourth repeat that binds to filamentous actin and a COOH-
terminal Src homology 3 domain, which recruits a variety of
other cellular proteins. Cortactin can stimulate the actin-
nucleation activity of the Arp2/3 complex alone or in com-
bination with N-WASP (Daly, 2004).
To address whether cortactin is involved in CaM- and
PKC-dependent pathways regulating endocytic transport,
we first studied the cellular location of cortactin in NRK cells
incubated with transferrin-TRITC. In untreated or rottlerin-
treated cells, cortactin was mainly located at the plasma
membrane and in some extent in transferrin-positive vesi-
cles (8.2%) (Figure 7A). However, inhibition of CaM by W13
resulted in an increased localization of cortactin in enlarged
endocytic structures, colocalizing with transferrin-TRITC
(18.2%). W13 and rottlerin together restored the normal
cortactin pattern (9.1%), which indicates that the endosomal
localization of cortactin is controlled by CaM and PKC
signaling.
To confirm the involvement of cortactin in the regulation
of EGFR recycling from early endosomes, cells were trans-
fected with two different cortactin siRNAs (Engqvist-Gold-
stein et al., 2004; Helwani et al., 2004) to knock down the
endogenous protein (Figure 7B). In both experiments, EGFR
recycling was recovered in cells treated with W13 (from 22
to 32%, consistent with the degree of cortactin depletion
shown by Western blotting). In control cells, knock down of
cortactin did not affect recycling rates (Figure 7B). However,
cortactin knock down inhibited EGFR degradation in con-
trols without modifying the W13 effect. Interestingly, these
results mimic the previously reported effects on EGFR traf-
ficking and degradation observed when PKC was inhibited
(Lladó et al., 2004).
Because these findings suggested that cortactin could be
regulated by CaM and PKC, we analyzed whether cortactin
binds to CaM and/or to PKC. Figure 8A shows a represen-
tative pull-down, using Sepharose-CaM, and it can be ob-
served that in the presence of calcium, cortactin binds to
CaM. Under the same conditions, RhoB was not found to
interact with CaM (Figure 8A). Finally, the interaction be-
tween cortactin and PKC was analyzed by means of coim-
munoprecipitation. Cells, ectopically expressing cortactin
Figure 6. N-WASP or WAVE are not involved in W13 effect. (A)
COS1 cells transiently expressing GFP-N-WASP-WA were incu-
bated with W13 (5 g/ml) for 90 min and EGF (100 ng/ml) for the
last 15 min at 37°C, fixed, and immunolabeled with anti-EGFR
(Alexa Fluor 594). Bar, 10 m. (B) NRK cells were preincubated with
W13 (7.5 g/ml) for 60 min and then treated with transferrin-TRITC
(50 g/ml) for 30 min at 37°C. Next, cells were fixed and stained
with anti-WAVE (Alexa Fluor 488). Bar, 10 m.
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and GFP-PKC or GFP (as control), were immunoprecipi-
tated using a polyclonal antibody against GFP. Cortactin was
coimmunoprecipitated with GFP-PKC, and this interaction
was increased by W13 treatment (Figure 8B). Reciprocally,
endogenous cortactin was immunoprecipitated using a mono-
clonal specific antibody and the coimmunoprecipitated endog-
enous PKC was increased after inhibition of CaM (Figure 8C).
Whether the interaction of cortactin and PKC modulated by
CaM has any functional significance in actin dynamics remains
to be investigated.
Together, the data presented in this study suggest that the
interplay of CaM/PKC might regulate actin polymeriza-
tion through cortactin-mediated activation of Arp2/3 com-
plex in early endosomes. Consequently, this might signifi-
cantly affect the trafficking along the recycling pathway.
DISCUSSION
In previous studies, we demonstrated the functional rela-
tionship between CaM and PKC in the control of EGFR and
Figure 7. Cortactin regulates recycling in the early endosomes. (A) NRK cells were preincubated for 30 min with W13 (5 g/ml), treated
with rottlerin (5 M) for 30 min, and then with transferrin (50 g/ml) for 15 min at 37°C. Cortactin (Alexa Fluor 488) and transferrin-TRITC
staining are shown. Bar, 10 m. (B) HeLa cells were transfected for 72 h with cortactin siRNA duplex 1 and 2 or GFP siRNA. Then, cells
internalized 125I-EGF (5 ng/ml; 7 min), and they were treated with W13 (7.5 g/ml) for 30 min at 37°C to measure recycling and degradation.
Each data point in the histogram represents the mean of a minimum of six replicates from two independent experiments for each siRNA
(SD). *p 	 0.05, **p 	 0.01, ***p 	 0.001 for Student’s t test, indicating statistical significances of differences between GFP and cortactin
siRNA-transfected cells. The degree of down-regulation of cortactin is demonstrated by Western blotting.
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transferrin trafficking in the early endocytic compartment.
Now, we report that when CaM is inhibited, PKC signaling
promotes the formation of an actin coat surrounding the
endosomes, which is critical for the inhibition of the ongoing
traffic from these structures. In particular, we provide evi-
dence that PKC, through Arp2/3 complex and cortactin,
generates an F-actin coat in early endosomes.
CaM and Actin Dynamics in the Early Endosomes
CaM may regulate the actin cytoskeleton through its effec-
tors, thereby controlling endo- and exocytic pathways
(Guerin and de Chastellier, 2000; Taunton et al., 2000; Qual-
mann and Kessels, 2002; Merrifield et al., 2004; Chang et al.,
2005). The assembly of actin coats on different populations of
endosomes and vacuoles has been reported as a result of a
variety of stimuli in distinct cell types throughout the endo-
cytic compartment. For example, the expression of Arf6
Q67L (constitutively active) or phosphatidylinositol 4-phos-
phate 5-kinase (PIP5K) blocks membrane traffic after endo-
cytosis and is characterized by enlarged vacuolar structures
that are phosphatidylinositol bisphosphate (PIP2)-enriched
and contain actin-coated membranes (Brown et al., 2001). In
addition, there are specific physiological situations such as
infection by Leishmania donovani promastigotes that lead to
inhibition of phagosome maturation and the accumulation
of periphagosomal F-actin in macrophages. Moreover, dom-
inant-negative Cdc42N17 inhibits LPG-mediated phagoso-
mal accumulation of F-actin and retention of Arp2/3 com-
plex and myosin (Lodge and Descoteaux, 2005a,b). In
addition, the deficiency of PIP2 5-phosphatase in Lowe Syn-
drome, leads to an elevation of PIP2, which affects actin
polymerization. Cells from patients with this syndrome
show a decrease of long actin stress fibers but an increase in
punctuate F-actin staining (Suchy and Nussbaum, 2002). In
Dictyostelium amoebae, it has also been demonstrated that an
actin coat prevents the clustering of late endosomes and
their aggregation (Drengk et al., 2003). Also, Gauthier et al.
(2007) demonstrated that sorting from GPI-activator pro-
tein–enriched early endosomal compartments to late endo-
somes requires dynamic F-actin structures on early endo-
somes. In this study, we observed a strong recruitment of
F-actin to the early endocytic compartment, responsible for
receptor recycling blockage, upon inhibition of CaM. There-
fore, actin polymerization and depolymerization must be
tightly regulated to guarantee the correct endocytic mem-
brane transport. Along these lines, in the present study the
use of actin depolymerizing agents (cytochalasin D, consti-
tutively active cofilin), demonstrates the involvement of F-
actin in EGFR recycling and degradation in normal cells.
Moreover, F-actin disruption by these agents, significantly
restores EGFR recycling but not its degradation when CaM
is inhibited. The inability to rescue the W13 effect on degra-
dation indicates that there might exist additional effects of
CaM inhibition, not mediated via actin, on the EGFR degra-
dative pathway. These data confirm the physiological rele-
vance of the actin cytoskeleton to preserve morphological
characteristics and receptor trafficking from the endosomal
compartment.
Furthermore, an F-actin coat surrounding early endo-
somes has also been described in cells overexpressing the
GTPase RhoB. RhoB is localized in the early and late endo-
cytic compartment and overexpression of the wild-type pro-
tein or a constitutively active mutant inhibits EGFR recy-
cling and degradation (Gampel et al., 1999; Fernandez-Borja
et al., 2005; Rondanino et al., 2007). Here, we demonstrated a
requirement for PKC downstream of RhoB in the formation
of an actin coat around enlarged endosomes. However,
upon RhoB depletion, inhibition of CaM still resulted in a
blockage of EGFR trafficking and the production of enlarged
endosomes labeled with phalloidin-TRITC. These results,
together with the lack of interaction between CaM and RhoB
in pull-down, indicate that although the mechanisms by
which RhoB overexpression and CaM inhibition induce ac-
tin-coated enlarged endosomes are different, they both ex-
hibit a PKC dependency.
Molecular Machinery Involved in the Formation of the
Actin Coat and the Consequent Inhibition of Endosome
Traffic
The involvement of CaM and PKC in the regulation of the
actin cytoskeleton in early endosomes was investigated by
means of immunolocalization, expression of dominant-neg-
ative proteins and RNAi knockdown techniques. After inhi-
bition of CaM, we identified a group of actin-binding pro-
teins associated with early endosomes, which are possible
Figure 8. CaM and PKC interact with cortactin. (A) Cellular
lysates from HeLa cells were incubated with CaM-Sepharose in the
presence of Ca2 or EGTA as described in Materials and Methods. All
bound fraction and 25 l of the unbound fraction or lysate was
loaded and the presence of cortactin and RhoB was analyzed by
Western blotting. (B) HeLa cells were cotransfected with cortactin
and GFP or GFP-PKC. After 24-h transfection, cells were incubated
for 30 min with or without W13 (10 g/ml) at 37°C. HeLa cell
extracts were incubated with anti-GFP polyclonal antibodies, and
the immunocomplex was pulled down by using protein A-Sepha-
rose. The presence of cortactin and GFP or GFP-PKC in the immu-
noprecipitates was analyzed by Western blotting by using anti-
cortactin and anti-GFP antibodies, respectively. (C) HeLa cells were
treated for 30 min  W13 (10 g/ml) at 37°C. Cell extracts were
incubated with anti-cortactin monoclonal antibody and pulled
down using protein G-Sepharose. The presence of PKC and cor-
tactin in the immunoprecipitates was analyzed by Western blotting.
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candidates to participate in the formation of the actin coat.
Among them are -actinin, annexins A1 and A2, MARCKS,
Arp2/3 complex, and cortactin. Conversely, we did not
detect endogenous cofilin, WAVE, or adducin proteins (data
not shown). Interestingly, the PKC/CaM-mediated loss of
MARCKS from the plasma membrane could explain the
reduction in number of stress fibers observed in these cells.
MARCKS is an important factor to anchor actin cytoskeleton
to the plasma membrane and also to regulate the structure of
actin fibers at this cellular location (Aderem, 1992; Hartwig
et al., 1992). Consequently, the PKC-triggered dissociation
of MARCKS from the plasma membrane, after W13 treat-
ment, could induce the detachment of microfilaments from
the plasma membrane.
Moreover, it has been described that the regulatory do-
main of PKC inhibits RhoA by an unknown mechanism
and decreases the level of stress fibers in neuronal cells (Ling
et al., 2004). Cdc42, and to a lesser extent Rac, are important
downstream factors in the pathway through which PKC
might mediate morphological and cytoskeletal effects, in-
cluding stress fibers loss (Troller and Larsson, 2006).
Interestingly, the presence of MARCKS, annexin A1, and
-actinin in endosomes relies on PKC activity when CaM is
inhibited (Supplemental Figure S1). Then, cortactin might
not be the only candidate involved in the W13-mediated
inhibition of membrane traffic. In fact, when the expression
of cortactin is down-regulated, we could not observe a full
recovery of EGF recycling. It is plausible that several pro-
teins could act in conjunction to produce the W13-altered
endosomes; therefore, further investigation is necessary to
address the involvement of these other candidates.
Our observations suggest that the Arp2/3 complex might
be responsible for the F-actin coat assembly when CaM is
not functional; p16, a member of the Arp2/3 complex, was
found in the endosomal membranes of W13-treated cells.
Moreover, when Arp2/3 complex is sequestered in the cy-
tosol by the overexpressed WA domain of N-WASP or by
N-WASPGBD (Supplemental Figure S2), the morphology
of the endosomes is restored. The quantitative analysis of
recycling of EGF-EGFR demonstrated the participation of
Arp2/3 complex to guarantee the correct recycling of the
EGF receptor from this endosomal compartment.
The activity of the Arp2/3 complex depends on NPFs
such as N-WASP and suppressor of cAMP receptor (SCAR)/
WAVE. These proteins provide a link between Cdc42 and
Rac1 activation, respectively, and regulation of actin poly-
merization (Machesky and Insall, 1999; Miki et al., 2000;
Higgs and Pollard, 2001). Indeed, the N-WASP/SCAR/
WAVE family of proteins have been implicated in promot-
ing motility of endosomes and other organelles (Taunton et
al., 2000; Southwick et al., 2003). Moreover, cortactin also has
NPF activity, binds F-actin and has been implicated in the
motility of endosomes (Daly, 2004, and references therein).
Thus, having demonstrated Arp2/3 complex involvement,
we attempted to identify which NPF was upstream of
Arp2/3 complex and therefore responsible for the blockage
of trafficking in W13-treated cells. The expression of a dom-
inant-negative mutant of N-WASP did not impair the for-
mation of actin-coated endosomes, indicating that N-WASP
was not involved. In addition, after CaM inhibition, WAVE
was not detected in endosomes. However, in W13-treated
cells, cortactin was increased in this compartment (in a
PKC-dependent manner) and a significant and consistent
recovery of EGFR recycling, but not EGFR degradation, was
observed upon RNAi-mediated knockdown of cortactin. Be-
sides, depletion of cortactin inhibits EGFR degradation in
control cells. These effects were similar to the previously
described when PKC was inhibited (Lladó et al., 2004).
There are some similarities and implications between the
participation of cortactin in the W13-induced enlargement of
endosomes and inhibition of membrane traffic to other re-
ported situations. Expression of PIP5K in differentiated
3T3L1 adipocytes results in the formation of enlarged vac-
uole-like structures coated with F-actin, cortactin, dynamin,
and N-WASP (Kanzaki et al., 2004). It has also been shown
that cortactin localizes to the bacterial vacuole formed upon
infection of epithelial cells with Chlamydia trachomatis
(Fawaz et al., 1997), Moreover, a role of the cortactin–dy-
namin complex in the regulation of post-Golgi transport has
been also reported previously (Cao et al., 2005). Thus, cor-
tactin may act at different membrane organelles to regulate
formation and scission of transport vesicles.
In addition, it has been shown that cortactin is involved in
the accumulation of actin filaments at coated pits and in
impairing vesicle release when cells are depleted of Hip1R.
Hip1R negatively regulates cortactin-stimulated actin poly-
merization to guarantee a transient and productive interac-
tion between coated pits and actin during vesicle internal-
ization (Engqvist-Goldstein et al., 2004; Le Clainche et al.,
2007). In fact, this same proposal could be formulated in our
study on CaM/cortactin and vesicles formation in endo-
somes. It has been described that CaM regulates budding-
exit from endosomes (de Figueiredo and Brown, 1995; Lladó
et al., 2004), and here we have shown that cortactin is also
responsible for the accumulation of actin filaments at endo-
somes when CaM is inhibited. Therefore, calcium-bound
CaM may regulate cortactin-stimulated actin polymerization
levels to achieve vesicle formation in endosomes.
Somewhat unexpectedly, we found that cortactin knock-
down inhibits EGFR degradation in HeLa cells, whereas we
previously reported that depletion of cortactin facilitated
EGFR degradation in cortactin-overexpressing cancer cell
lines (Timpson et al., 2005). Although this might seem con-
troversial, levels of cortactin before and after knockdown are
very different in both model systems, and high/low cortac-
tin expression levels seem to modulate EGFR trafficking
differently in common cell lines, such as HeLa, and cancer
cells. In our previous study using head and neck cancer cell
lines expressing very high levels of cortactin, its knockdown
reduced levels to those found in most cell lines. In the
present study, we strongly downregulated low endogenous
cortactin expression levels in a commonly used cell line.
Our model proposes that the dynamic assembly and dis-
assembly of F-actin is required for optimal endocytosis and
trafficking. Thus, perturbation of this process via elevated
(through CaM inhibition, cortactin overexpression or Hip1R
knockdown) or diminished actin polymerization (e.g., cy-
tochalasin D, cortactin knockdown in normal cells) can block
trafficking events.
Interestingly, we described here for the first time, a novel
interaction between cortactin and PKC, which is regulated
by CaM. The fact that this interaction was increased by W13
can be explained by the competitive binding of CaM and
PKC to cortactin. Actually, in a variety of substrates
(MARCKS, adducin, GAP 43), PKC and CaM compete for
the same binding domains (Chakravarthy et al., 1999). After
CaM inhibition, active PKC is responsible for the accumu-
lation of actin, through cortactin and Arp2/3 complex,
around endosomes. In this scenario, we hypothesize that
CaM may control the interaction between PKC and cortac-
tin. To some extent their activity regulates the actin cytoskel-
eton in early endosomes and consequently, endocytic fate.
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